Varian Medical Systems, Inc. (VAR) Director Timothy E. Guertin Sells 10,000 Shares

Varian Medical Systems, Inc. (NYSE:VAR) Director Timothy E. Guertin sold 10,000 shares of the firm’s stock in a transaction that occurred on Tuesday, January 2nd. The shares were sold at an average price of $111.46, for a total transaction of $1,114,600.00. Following the completion of the sale, the director now owns 2,161 shares in the company, valued at approximately $240,865.06. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website.

Varian Medical Systems, Inc. (NYSE VAR) traded up $0.33 during midday trading on Wednesday, hitting $111.31. 567,678 shares of the company were exchanged, compared to its average volume of 594,150. Varian Medical Systems, Inc. has a fifty-two week low of $76.94 and a fifty-two week high of $114.09. The firm has a market capitalization of $10,180.00, a price-to-earnings ratio of 40.33, a PEG ratio of 3.27 and a beta of 0.68.

Varian Medical Systems (NYSE:VAR) last posted its quarterly earnings data on Wednesday, October 25th. The medical equipment provider reported $1.09 EPS for the quarter, missing the Zacks’ consensus estimate of $1.19 by ($0.10). Varian Medical Systems had a net margin of 8.85% and a return on equity of 23.68%. The company had revenue of $739.00 million for the quarter, compared to analyst estimates of $741.69 million. During the same quarter in the prior year, the business earned $1.03 EPS. Varian Medical Systems’s revenue was down 1.1% compared to the same quarter last year. analysts anticipate that Varian Medical Systems, Inc. will post 4.25 earnings per share for the current fiscal year.

Several equities research analysts have commented on the stock. Evercore ISI assumed coverage on shares of Varian Medical Systems in a research note on Wednesday. They issued an “underperform” rating and a $100.00 price target on the stock. BTIG Research restated a “hold” rating on shares of Varian Medical Systems in a research note on Sunday, October 29th. Royal Bank of Canada set a $105.00 price objective on shares of Varian Medical Systems and gave the company a “hold” rating in a research note on Thursday, November 30th. Citigroup raised their price objective on shares of Varian Medical Systems from $119.00 to $121.00 and gave the company a “neutral” rating in a research note on Monday, October 30th. Finally, Zacks Investment Research lowered shares of Varian Medical Systems from a “hold” rating to a “sell” rating in a research note on Friday, October 27th. Three research analysts have rated the stock with a sell rating, eight have given a hold rating and one has given a buy rating to the company’s stock. Varian Medical Systems presently has a consensus rating of “Hold” and an average price target of $100.44.

A number of large investors have recently modified their holdings of the stock. Northwestern Mutual Wealth Management Co. boosted its holdings in Varian Medical Systems by 0.6% during the second quarter. Northwestern Mutual Wealth Management Co. now owns 1,912 shares of the medical equipment provider’s stock worth $197,000 after buying an additional 11 shares in the last quarter. People s United Financial Inc. boosted its holdings in Varian Medical Systems by 0.6% during the second quarter. People s United Financial Inc. now owns 6,279 shares of the medical equipment provider’s stock worth $648,000 after buying an additional 40 shares in the last quarter. Thrivent Financial For Lutherans boosted its holdings in Varian Medical Systems by 1.5% during the second quarter. Thrivent Financial For Lutherans now owns 3,480 shares of the medical equipment provider’s stock worth $359,000 after buying an additional 50 shares in the last quarter. Keybank National Association OH boosted its holdings in Varian Medical Systems by 1.4% during the second quarter. Keybank National Association OH now owns 4,487 shares of the medical equipment provider’s stock worth $463,000 after buying an additional 63 shares in the last quarter. Finally, Bradley Foster & Sargent Inc. CT boosted its holdings in Varian Medical Systems by 3.2% during the second quarter. Bradley Foster & Sargent Inc. CT now owns 3,319 shares of the medical equipment provider’s stock worth $342,000 after buying an additional 102 shares in the last quarter. Hedge funds and other institutional investors own 99.10% of the company’s stock.

ILLEGAL ACTIVITY NOTICE: “Varian Medical Systems, Inc. (VAR) Director Timothy E. Guertin Sells 10,000 Shares” was first reported by American Banking News and is the property of of American Banking News. If you are reading this piece of content on another domain, it was stolen and reposted in violation of US & international trademark & copyright laws. The correct version of this piece of content can be viewed at https://www.americanbankingnews.com/2018/01/03/varian-medical-systems-inc-var-director-timothy-e-guertin-sells-10000-shares.html.

Varian Medical Systems Company Profile

Varian Medical Systems, Inc is a manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy.

Insider Buying and Selling by Quarter for Varian Medical Systems (NYSE:VAR)

Receive News & Ratings for Varian Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Varian Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply